Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.
No takes yet. Share an insight, caveat, or question.
Skarbnik et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: